Director or Senior Director, Regulatory CMC

Who we are: Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit  www.kymeratx.com or follow us on  X (formerly Twitter)  or  LinkedIn . How we work: • PIONEER : We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines. • COLLABORATE : We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine. • BELONG : We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard. How you’ll make an impact: • Lead the development and execution of global regulatory CMC strategies for degrader programs across all stages of development, from early-stage activities through late-stage development and approval with specific emphasis on late-stage activities. • Serve as the regulatory CMC lead for multiple programs, partnering closely with CMC, Quality, Non-Clinical, and Clinical Development teams to align regulatory strategy with program timelines. • Author, review, and approve CMC content for regulatory submissions, including INDs/CTAs, briefing documents, NDA/MAA modules, annual reports, and amendments/supplements. • Provide strategic regulatory CMC guidance to senior leadership regarding health authority interactions, submission risk, and mitigation planning. • Lead preparation for, and participate in, meetings and correspondence with FDA, EMA, and other global health authorities on CMC matters. • Monitor, interpret, and communicate evolving global CMC regulatory guidance and requirements, advising cross-functional teams on impact and implementation. • Collaborate with and provide regulatory oversight of CDMOs and other external manufacturing/testing partners to ensure regulatory compliance and submission readiness. • Scale and lead the Regulatory Affairs CMC function as the pipeline and organization grow. Skills and experience you’ll bring: • BS, MS, or PhD in Chemistry, Pharmaceutics, Biochemistry, Chemical Engineering, or a related scientific discipline. • 10+ years of progressive Regulatory Affairs CMC experience in the biotechnology or pharmaceutical industry. • Deep experience in late-stage (pivotal trials through NDA/MAA and post-approval) regulatory CMC activities. • Extensive hands-on small molecule CMC experience, including direct work on small molecule drug substance and drug product development, control strategy, and lifecycle management. • Demonstrated success independently authoring, reviewing, and managing CMC content for small molecule INDs/CTAs and marketing applications (NDA/MAA), with hands-on experience preparing for and participating in health authority interactions. • Strong working knowledge of global CMC regulatory requirements and guidance for small molecule products across the product lifecycle (FDA, EMA, ICH, and other regional health authorities). • Experience with small molecule analytical method development/validation, specification setting, and post-approval change management. • Exce